• Contact
  • Login
  • Contact
  • Login
  • TTM2

  • Menu
  • Contact
  • Login
  • About the study
    • History
    • Who are we
  • News
  • Documents
  • Sites
  • Partners
  • Substudies

New publication from TTM1 - Serum Tau

09 November 2017

Published in this month's Annals of Neurology, Niklas Mattsson and colleagues measured the neuronal protein tau as a predictor of neurological outcome after cardiac arrest. Results seem to indicate that Tau improves outcome prediction compared to NSE, which is the currently recommended by guidelines. There was no difference in serum tau levels between patients managed at 33°C or 36°C. We are looking forward to validating these results in TTM2. 

Find the article here: http://bit.ly/2jdrKV6

 

News

Past 500

15 January 2019

Newsletter Dec - 12

12 December 2018

Screening Log

12 December 2018

Inclusion update (Nov 19) - 332 participants

19 November 2018

Neurofilament article in JAMA Neurology

30 October 2018

Inclusion update (Oct 25) - 267 participants,

25 October 2018

Neuroprognostication videos

17 September 2018

Site inclusion update

04 September 2018

August Update - 192 participants

29 August 2018

eCRF going live and some temporary procedures.

04 May 2018

Pages

  • « first
  • ‹ previous
  • 1
  • 2
  • 3
  • 4
  • next ›
  • last »

Helsingborg Hospital 
Anaesthesiology and Intensive Care 
Charlotte Yhlens gata 10
251 87 Helsingborg, Sweden
ttm2@ttm2trial.org

Skåne University Hospital
Center for Cardiac Arrest
Barngatan 2A, Practicum
22185 Lund, Sweden
ttm2@ttm2trial.org